NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Spero Therapeutics, Inc. Common Stock Share Price Chart

O H L

Spero Therapeutics, Inc. Common Stock Performance Overview

Days Range
$1.12Low
$1.13High

Markets Today

Previous Close$1.12
Open$1.13
Volume181,774
Day's Range$1.12 - $1.13
52W Range$1.08 - $3.08
Market Cap$64.64 M

Historical Performance

1M Returns-6.67
3M Returns-50.88
6M Returns-54.47
1Y Returns-44.00
5Y Returns-94.15
10Y ReturnsNA

Spero Therapeutics, Inc. Common Stock Fundamentals

Market Cap$64.64 M
Dividend yield0.00
PE Ratio29.16
PEG RatioN/A
Revenue$66.80 M
ROE TTM0.16
EPS TTM$0.04
Quarterly Earnings Growth YOYN/A
PB Ratio1.46
EBITDA$7.16 M
Profit Margin12.83
Market Cap$64.64 M
Dividend yield0.00
PE Ratio29.16
PEG RatioN/A
Revenue$66.80 M
ROE TTM0.16
EPS TTM$0.04
Quarterly Earnings Growth YOYN/A
PB Ratio1.46
EBITDA$7.16 M
Profit Margin12.83

Spero Therapeutics, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$5.87 M$14.19 M$5.44 M$41.30 M$258.00 K$0
Gross Profit +$5.87 M$14.19 M$5.44 M$41.30 M$258.00 K$0
Operating Income -$14.73 M-$2.44 M-$7.92 M$31.41 M-$7.54 M-$9.93 M
EBITDA -$14.56 M-$2.36 M-$7.33 M$31.41 M-$7.54 M-$9.93 M
Interest Expense $0$0$0$0$0$0
Depreciation $175.00 K$83.00 K$587.00 K$0$0$0
Income Before Tax -$13.87 M-$1.70 M-$7.38 M$31.78 M-$7.20 M-$9.55 M
Income Tax Expense $0$0$0$261.00 K$0$0
Net Income +-$13.87 M-$1.70 M-$7.38 M$31.52 M-$7.20 M-$9.55 M
Net Profit Margin -236.06%-11.98%-135.65%76.33%-2791.86%-

Spero Therapeutics, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $56.00 K$56.00 K$56.00 K$56.00 K$58.00 K$58.00 K
Reserve & Surplus -$473.50 M-$475.20 M-$482.59 M-$451.07 M-$458.27 M-$467.82 M
Non-Current Liabilities $14.74 M$14.35 M$14.03 M$1.03 M$598.00 K$134.00 K
Current Liabilities $29.16 M$14.95 M$13.65 M$8.87 M$5.49 M$8.43 M
Total Liabilities $43.90 M$29.29 M$27.68 M$9.90 M$6.09 M$8.56 M
Fixed Assets $0$0$0$0$0$0
Current Assets $74.71 M$56.94 M$52.32 M$67.29 M$57.61 M$51.58 M
Total Assets $77.71 M$62.12 M$54.17 M$68.92 M$59.02 M$52.77 M

Spero Therapeutics, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$13.87 M-$1.70 M-$7.38 M$31.52 M-$7.20 M-$9.55 M
Operating Cash Flow -$4.00 M-$17.69 M$17.42 M-$8.35 M$15.86 M-$5.36 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $0$0$0$0$0$0
Change in Cash -$4.00 M-$17.69 M$17.42 M-$8.35 M$15.86 M-$5.36 M

Spero Therapeutics, Inc. Common Stock Return Calculator

The Spero Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$585
Invested Amount$10,000
Est. Returns$-9,415
Invest in USA Stock Today

About Spero Therapeutics, Inc. Common Stock

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

FAQs

Spero Therapeutics, Inc. Common Stock (SPRO) share price as of September 18, 2026 is $1.12. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Spero Therapeutics, Inc. Common Stock (SPRO) Share by opening an international trading account with Angel One.
Purchasing Spero Therapeutics, Inc. Common Stock (SPRO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Spero Therapeutics, Inc. Common Stock (SPRO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Spero Therapeutics, Inc. Common Stock (SPRO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Spero Therapeutics, Inc. Common Stock on September 18, 2026, is $64.64 M.
Spero Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Spero Therapeutics, Inc. Common Stock (SPRO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91